CoherusBioSciences, Inc. (CHRS) Stock on the Rise Following Success of JUPITER-02 Pivotal Study
CoherusBioSciences, Inc. (CHRS) stock prices were up by 3.53% shortly after market trading commenced on June 4th, 2021, bringing the price per share up to USD$13.50 early on in the trading day. JUPITER-02 Results The company recently announced the successful results from its pivotal study, JUPITER-02, which was a randomized, double-blind, placebo-controlled Phase 3 clinical […]
